Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Multi4

Financiado

Multi4 - the first surgical instrument for bladder cancer treatment through a 20...

Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedure Bladder Cancer (BC) is the 5th most common cancer in Europe with the incidence of 175.000 cases annually and has the highest lifetime treatment cost of all cancers. At the diagnostic step, a cystoscope is used. Usually, no biopsie... ver más

31/07/2024

MULTI4 MEDICAL AB

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

MULTI4 MEDICAL AB No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-07-31

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU ExpectedOutcome:Project results are expected to contribute to the following expected outcomes:

Innovación

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

MULTI4 MEDICAL AB

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PTQ-11-05057 BLADDERMATRIX, INVESTIGACIÓN, DESARROLLO Y VALIDACIÓN DE MÉT... 124K€ Cerrado

PTQ-10-03892 PROYECTO BLADDERMATRIXINVESTIGACIÓN, DESARROLLO Y VALIDACIÓN... 120K€ Cerrado

TEC2013-48251-C2-1-R PLANIFICACION Y GUIADO MULTIMODAL EN CIRUGIA Y TRATAMIENTO D... 128K€ Cerrado

PTQ-11-04503 BLADDERMATRIX INVESTIGACIÓN, DESARROLLO Y VALIDACIÓN DE MÉTO... 80K€ Cerrado

PROSTATOR Reliable urinary test for the diagnosis of prostate cancer 150K€ Cerrado

RTC-2017-6379-1 Mejora del tratamiento del cáncer de vejiga por Baciloterapi... 901K€ Cerrado

Duración del proyecto: 13 meses Fecha Inicio: 2023-06-01
Fecha Fin: 2024-07-31

Líder del proyecto

MULTI4 MEDICAL AB No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Bladder Cancer (BC) is the 5th most common cancer in Europe with the incidence of 175.000 cases annually and has the highest lifetime treatment cost of all cancers. At the diagnostic step, a cystoscope is used. Usually, no biopsies are taken as there are no efficient methods to do so in the outpatient care. If the patient has suspected cancer seen on the monitor, they are scheduled for a surgery. At the surgery step, the biopsies are taken and the cancer is removed using a resectoscope. The procedure is difficult to perform. The instrument used is hard (metal, up to 12 mm in diameter) and inflexible (can damage the urethra). There is a high risk of cancer reseeding elsewhere in the bladder. Up to 75 % of BC patients relapse within 5 years. The related costs in the EU are estimated at € 5 billion annually. No development has taken place since the 1960 when the existing instruments were developed. We have developed and patented the first medical device (called Multi4) which allows for local treatment of BC through flexible cystoscopy during one visit to the urologist. The instrument has 4 functions: 1. Inject local anaesthesia through a thin needle 2. Pieces of the cancer are cut by the specially coated forceps. Bleeding is stopped immediately. 3. The cancer tissue is automatically transported out through the instrument itself. 4. When the forceps are closed, they become a burning electrode used to burn the surface where the cancer was located and ensure that all cancer cells have been killed. With the Multi4 platform, the patient can have their cancer treated at the first visit to the urologist. The procedure takes 20 minutes. This technology can thus disrupt the existing healthcare pathways where BC is treated through expensive and complicated surgeries. The proposed project will develop a go-to-market strategy for this ground-breaking deep tech innovation and empower the female founder to scale the company.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores